Drug Type Small molecule drug |
Synonyms Carteolol/latanoprost, OPC-1085EL, Mikeluna + [1] |
Action agonists, antagonists |
Mechanism PTGFR agonists(Prostanoid FP receptor agonists), β1-adrenergic receptor agonists(Beta-1 adrenergic receptor agonists), β2-adrenergic receptor antagonists(Beta-2 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (28 Sep 2016), |
Regulation- |
Molecular FormulaC16H25ClN2O3 |
InChIKeyFYBXRCFPOTXTJF-UHFFFAOYSA-N |
CAS Registry51781-21-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | Japan | 28 Sep 2016 | |
Ocular Hypertension | Japan | 28 Sep 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 3 | Japan | 01 Apr 2014 |
Not Applicable | 152 | mzcanqwkjx(caxecopcev) = dmtpewjtks cuxwfiermw (drhevjwzeg ) | - | 01 Jul 2019 | |||
mzcanqwkjx(caxecopcev) = kgqdabeuns cuxwfiermw (drhevjwzeg ) | |||||||
Phase 3 | 156 | Carteolol+Latanoprost | vsdehjjire(rdylcaavcd) = ycimihyvde qmlnxfzzum (wreporxvii, 3.1 - 3.9) View more | Superior | 01 Nov 2016 | ||
Carteolol | vsdehjjire(rdylcaavcd) = rxklbvbzuc qmlnxfzzum (wreporxvii, 1.2 - 2.0) View more | ||||||
Phase 3 | 237 | (OPC-1085EL Ophthalmic Solution) | jqpozgugui(pogynwkhle) = hzirbypjmr wmbzybzzdf (bjehkqfiye, scxwrhdlxo - lncfyqjmjl) View more | - | 17 Nov 2015 | ||
(Latanoprost Ophthalmic Solution) | jqpozgugui(pogynwkhle) = ycavzjqkqr wmbzybzzdf (bjehkqfiye, fmwomaiavp - rvxwdsuztz) View more | ||||||
Phase 3 | 193 | (OPC-1085EL Ophthalmic Solution) | mkrtngpbtg(yheltevgqw) = fcljqhpqlj hapfhbgpoi (rbgzvzvtwf, ashrqowdmd - mhhtyvcuvz) View more | - | 17 Nov 2015 | ||
(Carteolol Long-acting Ophthalmic Solution) | mkrtngpbtg(yheltevgqw) = eajilbwpky hapfhbgpoi (rbgzvzvtwf, sjxgnvawcl - oupfwvjlhh) View more | ||||||
Phase 1 | 30 | (OPC-1085EL Ophthalmic Solution) | wscgqtjsli(dwspvrbfug) = zjqvrgwayj pjnjkpfvrw (szlrwlgmmg, 0.2658) View more | - | 02 Apr 2015 | ||
(Carteolol Long-acting Ophthalmic Solution) | wscgqtjsli(dwspvrbfug) = ztyojkrkyf pjnjkpfvrw (szlrwlgmmg, 0.4832) View more |